Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs Cyclophosphamide in Acquired Hemophilia A
NCT00306670Phase 3Terminated
- Sponsor
- Georgetown University
- Start
- Apr 2006
- Primary completion
- Jan 2011
- Modality
- Monoclonal Antibodies
01
Overview
Phase 3, randomised, open-label trial of rituximab in acquired hemophilia A (AHA), sponsored by Georgetown University. Started Apr 2006; status: terminated.
02
Drugs
rituximab
03
Conditions
acquired hemophilia A (AHA)
Beyond the preview
Go deeper on NCT00306670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306670.